Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-02-03Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
-
CLINICAL_TRIALS study record update · 2025-02-03A Phase 1, Open-label, Multicenter, Dose-escalation Study of CK-301 Administered Intravenously as a Single Agent to Subjects With Advanced Cancers
-
CLINICAL_TRIALS study record update · 2025-01-29A Phase II Randomized Trial of Intralesional Talimogene Laherparepvec (TALIMOGENE LAHERPAREPVEC) With or Without Radiotherapy for Cutaneous Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-01-28Phase II Randomized Study Evaluating a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer
-
CLINICAL_TRIALS study record update · 2025-01-24A Prospective Observational Study in Patients Receiving Adjuvant Nivolumab Therapy for Resected Melanoma in Australia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-01-23Phase I Trial of Phenformin With Patients With Combination BRAF Inhibitor/MEK Inhibitor in Patients With BRAFV600E/K-mutated Melanoma
-
CLINICAL_TRIALS study record update · 2025-01-22Statins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosis
-
CLINICAL_TRIALS study record update · 2025-01-22An Open-label, Phase 2 Basket Study of SEA-CD40 Combination Therapies in Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2025-01-15A Phase 1/2 Safety and Efficacy Dose Escalation / Dose Expansion Study of a CAB-ROR2-ADC, Alone and in Combination With a PD-1 Inhibitor, in Patients With Advanced Solid Tumors (Ph1) and Melanoma and NSCLC Patients (Ph2)
-
CLINICAL_TRIALS study record update · 2025-01-14A Phase Ib/II Randomised Open Label Study of BGB324 in Combination With Pembrolizumab or Dabrafenib/Trametinib Compared to Pembrolizumab or Dabrafenib/Trametinib Alone, in Patients With Advanced Non-resectable (Stage IIIc) or Metastatic (Stage IV) Melanoma
-
CLINICAL_TRIALS study record update · 2025-01-06A Multi-center, Open-label Phase II Study to Evaluate the Safety and Efficacy of YH003 in Combination with Toripalimab (anti-PD-1 MAb) in Patients with Unresectable/metastatic Melanoma and Pancreatic Ductal Adenocarcinoma (PDAC)
-
CLINICAL_TRIALS study record update · 2025-01-01Phase II Study Investigating the Efficacy of Neoadjuvant Dual Checkpoint Inhibition and Cryoablation Therapy in Children, Adolescents, and Young Adults With Relapsed/Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2024-12-30Botensilimab and Balstilimab Expanded Access Program
-
CLINICAL_TRIALS study record update · 2024-12-27A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2024-12-27An Open-Label, Dose-Escalation Phase 1b/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Modakafusp Alfa (TAK-573) as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2024-12-24Mature Dendritic Cell Vaccination Against Mutated Antigens in Patients With Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2024-12-24A Phase 1B/2A Study of the Safety, Tolerability and Initial Efficacy of Oral AMXT 1501 Dicaprate and Intravenous Difluoromethylornithine (DFMO) in Patients With Cancer
-
CLINICAL_TRIALS study record update · 2024-12-20Phase 1/2 Open Label, Safety and Preliminary Efficacy Study of a Live Biotherapeutic Product (CJRB-101) in Combination With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer
-
CLINICAL_TRIALS study record update · 2024-12-19A Phase 2, Open-label, Multicenter Study of IBI363 (PD1-IL2m) in Subjects with Advanced Solid Malignancies
-
CLINICAL_TRIALS study record update · 2024-12-18The Registry of Oncology Outcomes Associated With Testing and Treatment (ROOT)
-
CLINICAL_TRIALS study record update · 2024-12-11A Phase Ib Study, Evaluating the Safety, Tolerance and Efficacy of PRJ1-3024 Capsules in China Subjects with Unresectable Local Advanced or Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2024-12-06Cognitive Function in Patients Treated for Melanoma With Adjuvant Immune Checkpoint Inhibitors: A Controlled Prospective Observational Study
-
CLINICAL_TRIALS study record update · 2024-12-06Family History App in Personalized Medicine (FHAMe): A Pilot Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-12-04PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9
-
CLINICAL_TRIALS study record update · 2024-12-04Ontario-wide Cancer TArgeted Nucleic Acid Evaluation